Going straight to the point: intra-BM injection of hematopoietic progenitors
Psychological effects of hematopoietic SCT on pediatric patients, siblings and parents: a review
Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study
Reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation results in durable disease-free and overall survival in patients with poor prognosis myeloid and lymphoid malignancies: eighty-month follow-up
Relationship between tacrolimus blood concentrations and clinical outcome during the first 4 weeks after SCT in children
Does location matter? Rural vs urban outcomes after blood and marrow transplantation in a population-based Canadian cohort
Reevaluation of the National Institutes of Health criteria for classification and scoring of chronic GVHD
Cerebral angiitis in four patients with chronic GVHD
The number of infused CD34+ cells does not influence the incidence of GVHD or the outcome of allogeneic PBSC transplantation, using reduced-intensity conditioning and antithymocyte globulin
Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT
Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: a comparison with matched unrelated donors as stem cell source
The risk of early and late CMV DNAemia associated with Campath use in stem cell transplant recipients
Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomes
Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study
Consolidation with high-dose chemotherapy and stem cell support for responding patients with metastatic soft tissue sarcomas: prospective, single-institutional phase II study
Pre-transplant risk factors affecting outcome in Hurler syndrome
Tumor cell contamination in ovarian tissue cryopreserved before gonadotoxic treatment: should we systematically exclude ovarian autograft in a cancer survivor?
Invasive microsporidiosis in allogeneic haematopoietic SCT recipients
Successful unrelated donor cord blood transplantation for adult sickle cell disease and Hodgkin lymphoma
Outcomes of reduced-intensity conditioning allo-SCT for Hodgkin's lymphoma: a national review by the Canadian Blood and Marrow Transplant Group
Long-term outcomes in adult patients below the age of 55 years with acute lymphoblastic leukemia treated with chemotherapy or allogeneic BM transplant in first CR